Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVSEF crawled time : 20:00 save search
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published: 2024-03-27 (Crawled : 20:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ERAS | $1.925 -3.75% -3.9% 730K
|
|
| O: 17.48%
H: 6.94%
C: -14.88%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
business year financial results
Urinary Tract Infection Treatment Market Projected to Reach US$ 10.73 Billion by 2030: Telemedicine Integration Revolutionizes UTI Care, Self-Care Products Gain Momentum
Published: 2024-02-29 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -2.33%
H: 3.68%
C: 2.44%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 1.03%
H: 0.14%
C: 0.05%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.26%
H: 0.18%
C: 0.05%
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
|
| O: 0.37%
H: 0.27%
C: -0.1%
integration reach momentum infection treatment market
Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances
Published: 2024-02-14 (Crawled : 20:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.26%
H: 0.87%
C: 0.32%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.48%
H: 1.56%
C: 1.48%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: -0.75%
H: 0.86%
C: 0.41%
biosimilar report global therapy growth market
Global Orphan Drugs Market Research Report 2023: Market to Reach $415.2 Billion by the End of 2028 - Premium Pricing of Orphan Drugs and Increasing Collaborations/Licensing Agreements Bolsters Growth
Published: 2024-01-17 (Crawled : 20:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 0.1%
H: 0.76%
C: 0.76%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: -2.34%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: -0.6%
H: 0.34%
C: 0.34%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -0.78%
H: 0.59%
C: 0.57%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.54%
H: 1.55%
C: 1.33%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -1.1%
H: 1.63%
C: 1.59%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -0.51%
H: 1.33%
C: 0.93%
report reach research global growth market
Global Antibody Fragments Market Research Report 2023: Market to Reach $9.6 Billion by 2028 - Increasing Investments in Biopharmaceuticals Driving Growth
Published: 2024-01-15 (Crawled : 20:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -2.03%
H: 0.05%
C: 0.05%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.16%
H: 0.43%
C: 0.07%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: -1.45%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -1.34%
H: 0.0%
C: 0.0%
investments report antibody reach research global growth market
Alzheimer's Disease Therapeutics Market size to grow by USD 5.41 billion from 2023-2028; North America to account for 39% of market growth - Technavio
Published: 2023-12-12 (Crawled : 20:00) - prnewswire.com
TEVJF | $12.37 -24.22% 380
|
Health Technology
|
| O: -10.21%
H: 0.0%
C: 0.0%
GIKLY | $4.56 132.75% 260
|
Manufacturing
|
| O: 2.92%
H: 0.0%
C: 0.0%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.71%
H: 0.88%
C: 0.85%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.17%
H: 1.17%
C: 0.86%
DNLI | $17.35 -2.75% -2.82% 1.1M
|
Health Technology
|
| O: 2.9%
H: 8.82%
C: 8.56%
BIIB | $195.16 -0.83% -0.85% 870K
|
Health Technology
|
| O: 0.09%
H: 2.58%
C: 2.52%
america disease alzheimer's therapeutics growth market
REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights
Published: 2023-08-02 (Crawled : 20:00) - prnewswire.com
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -1.38%
H: 0.77%
C: 0.7%
RARE | $42.32 -1.28% -1.3% 890K
|
Health Technology
|
| O: 0.0%
H: 0.85%
C: -2.48%
RGNX | $17.49 -2.94% -3.03% 300K
|
Health Technology
|
| O: -7.2%
H: 10.26%
C: -0.34%
financial results
Novartis will appeal to U.S. Court of Appeals to uphold validity of Entresto® combination patent; maintains 2023 guidance and mid-term outlook
Published: 2023-07-07 (Crawled : 20:00) - globenewswire.com
FNCTF | $11.128 -20.84% 580
|
Communications
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
entresto novartis
Chinook Therapeutics to Present Updated Data from Zigakibart (BION-1301) Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) at the 60th European Renal Association (ERA) Congress
Published: 2023-06-12 (Crawled : 20:00) - globenewswire.com
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -0.26%
H: 0.15%
C: -0.42%
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: -0.21%
H: 0.26%
C: -0.08%
bion-1301 nephropathy association renal trial therapeutics igan
Sarcoidosis therapeutics market size to grow by USD 64.82 million from 2021 to 2026: Rising awareness about sarcoidosis to boost the market - Technavio
Published: 2023-04-05 (Crawled : 20:00) - prnewswire.com
MNK | News | $0.3402 -0.06% 540K
|
n/a
|
| O: 0.17%
H: 0.17%
C: -7.04%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.0%
H: 0.63%
C: 0.21%
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: 1.02%
H: 0.45%
C: 0.2%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 1.34%
H: 0.23%
C: -0.08%
therapeutics market
Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
| Email alert
Add to watchlist
CSLLY | $89.5 3.3% 44K
|
n/a
| Email alert
Add to watchlist
MNK | News | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
MNKPF | News | $17.25
|
n/a
| Email alert
Add to watchlist
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
| Email alert
Add to watchlist
ENDP 6 d | $0.2926 -9.6%
|
Health Technology
| Email alert
Add to watchlist
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
| Email alert
Add to watchlist
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
UCBJY | $63.0 -4.38% 11K
|
Manufacturing
| Email alert
Add to watchlist
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
ALPMF | $9.48 43.47% 1.7K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | $92.966 -2.18% 630
|
Health Technology
| Email alert
Add to watchlist
BHC | $8.74 1.28% 0.11% 2.5M
|
Health Technology
| Email alert
Add to watchlist
UCBJF | $126.05 -39.66% 100
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
ENDPQ 6 d | $0.0018 -50.0% 420K
|
n/a
| Email alert
Add to watchlist
CMXHF | $180.75 -19.21% 33
|
n/a
| Email alert
Add to watchlist
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
| Email alert
Add to watchlist
MNKKQ | News | $0.02
|
Manufacturing
| Email alert
Add to watchlist
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
NVO | $123.45 -0.36% 0.03% 3M
|
Health Technology
| Email alert
Add to watchlist
global report
Osteoarthritis therapeutics market to grow at a CAGR of 8.97% from 2022 to 2027: Growth opportunities led by Abbott Laboratories and Alvogen Iceland ehf among others- Technavio
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.12%
H: 0.0%
C: -1.26%
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: 0.09%
H: 0.18%
C: -1.29%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.11%
H: 0.05%
C: -1.21%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.32%
H: 0.17%
C: -1.53%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 0.11%
H: 0.23%
C: -2.8%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
ANIK | $25.6 1.15% 1.13% 52K
|
Health Technology
|
| O: -4.29%
H: 1.19%
C: -6.23%
osteoarthritis therapeutics growth market
Global Global Antimalarial Drugs Market Research Report 2022-2028 Featuring Cipla, GSK, Ipca, Merck, Novartis, Zydus Cadila, Sun Pharma, Strides Pharma, Glenmark Pharma, Lincoln Pharma
Published: 2023-02-17 (Crawled : 20:00) - prnewswire.com
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
pharma research global report market
Dry Eye Products Global Market Report 2022: Sector to Reach $9.68 Billion by 2028 at a 5.1% CAGR
Published: 2023-01-16 (Crawled : 20:00) - prnewswire.com
PBH | $68.06 -0.12% -1.68% 150K
|
Health Technology
|
| O: -0.27%
H: 1.52%
C: -0.9%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 2.34%
H: 0.04%
C: -0.87%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.13%
H: 0.85%
C: -0.63%
global report eye market
Insights on the Allergic Conjunctivitis Global Market to 2031 - by Drug Class, Disease Type, Distribution Channel and Region
Published: 2023-01-05 (Crawled : 20:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: -1.84%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.35%
H: 1.43%
C: 1.28%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.74%
H: 0.44%
C: 0.07%
BHC | $8.74 1.28% 0.11% 2.5M
|
Health Technology
|
| O: 0.84%
H: 4.71%
C: 3.46%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.83%
H: 1.98%
C: 1.04%
drug global disease distribution market
Global Epigenetics Market Analysis Report 2022: Growing Prevalence of Cancer and Other Diseases Significantly Driving Growth
Published: 2022-12-01 (Crawled : 20:00) - prnewswire.com
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -1.08%
H: 1.44%
C: 1.28%
global report growing cancer growth market
Global Precision Medicine Market to Reach $146.57 Billion by 2028 at a 12.1% CAGR
Published: 2022-11-18 (Crawled : 20:00) - prnewswire.com
ILMN | $117.66 -2.89% -2.97% 1.7M
|
Health Technology
| Email alert
Add to watchlist
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
TMO | $554.55 -0.6% 0.0% 1M
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
LH | $201.93 -0.68% 0.0% 690K
|
Health Services
| Email alert
Add to watchlist
global market
Worldwide Radiotheranostics Industry to 2027 - By Radioisotope, Application, End-user, Competitive Landscape and Region
Published: 2022-11-09 (Crawled : 20:00) - prnewswire.com
TRUMF | $16.504 -17.59% 1.7K
|
Health Technology
|
| O: 2.88%
H: 1.93%
C: -0.99%
TRUMY | $16.53 0.79% 31K
|
Manufacturing
|
| O: 0.27%
H: 3.27%
C: 3.27%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
BSX | $68.12 1.01% 0.02% 6.6M
|
Health Technology
|
| O: 3.26%
H: 1.01%
C: 0.76%
YMAB | $15.15 1.61% 1.58% 440K
|
Health Technology
|
| O: 4.96%
H: 9.22%
C: 9.22%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 5.57%
H: 9.88%
C: 7.49%
ATNM | $7.74 -8.29% -0.38% 370K
|
Health Technology
|
| O: 3.4%
H: 3.63%
C: 2.25%
Pleurodynia Treatment Market Size to USD 24.61 Mn, Growing Prevalence of Viral Infections to Boost Market Growth - Technavio
Published: 2022-11-08 (Crawled : 20:00) - prnewswire.com
RBGPF | $51.8 6.46% 8K
|
Consumer Non-Durables
|
| O: -1.91%
H: 4.89%
C: 0.2%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.44%
H: 0.0%
C: -3.27%
RBGLY | $10.49 -2.05% 5.1M
|
Manufacturing
|
| O: -1.61%
H: 1.0%
C: -0.16%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.84%
H: 1.22%
C: 0.55%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.06%
H: 1.27%
C: 0.56%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 0.27%
H: 1.36%
C: -0.45%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.72%
H: 0.69%
C: -0.23%
treatment growing infections growth market
Pharmaceutical Drug Delivery Global Market Report 2022: Adoption of Nano-Based Drug Delivery Systems Presents Opportunities
Published: 2022-10-11 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.93%
H: 0.0%
C: -0.17%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: -0.15%
H: 0.61%
C: 0.09%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -0.07%
H: 0.48%
C: -0.66%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 1.29%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.0%
H: 0.67%
C: -0.2%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.07%
H: 1.92%
C: -0.86%
BSX | $68.12 1.01% 0.02% 6.6M
|
Health Technology
|
| O: 0.38%
H: 0.35%
C: -0.28%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.09%
H: 1.0%
C: -1.17%
MMM | $91.05 -0.27% 0.31% 3M
|
Producer Manufacturing
|
| O: -0.25%
H: 1.04%
C: 0.35%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -0.67%
H: 0.95%
C: 0.25%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: -0.44%
H: 1.79%
C: 0.85%
drug global report market
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.